Compare IMTX & YSWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMTX | YSWY |
|---|---|---|
| Founded | N/A | N/A |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2020 | 2021 |
| Metric | IMTX | YSWY |
|---|---|---|
| Price | $8.49 | $20.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 589.4K | 275.1K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.91 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.06 | $18.92 |
| 52 Week High | $12.41 | $26.34 |
| Indicator | IMTX | YSWY |
|---|---|---|
| Relative Strength Index (RSI) | 44.21 | 32.75 |
| Support Level | $8.36 | $18.92 |
| Resistance Level | $10.51 | $21.42 |
| Average True Range (ATR) | 0.33 | 0.97 |
| MACD | -0.02 | -0.35 |
| Stochastic Oscillator | 53.88 | 13.35 |
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.